Cancer of the cervix is the second most common cancer among women worldwide, with about 500,000 new patients’ diagnosed and over 250,000 deaths every year. It is a major cause of morbidity and mortality among women in resource-poor settings, especially in Africa. The majority of cancers (over 80%) in sub-Saharan Africa are detected in late stages, predominantly due to lack of information about cervical cancer and prevention services. Late-stage disease is associated with low survival rates after surgery or radiotherapy. In addition, these treatment modalities may be lacking altogether, or too expensive and inaccessible, for many women in low resource countries. Cervical cancer is potentially preventable, and there are effective screening and treatment programmes that can lead to a significant reduction in the morbidity and mortality associated with this cancer.